FDA Law Blog: Biosimilars

JULY 21, 2024

The plaintiffs in that case— Alliance of Nurses for Healthy Environments, et al v. FDA — were a group of environmentally conscious interest groups that brought suit against FDA to better regulate the use some antimicrobials in livestock and poultry. Alliance for Hippocratic Medicine et al. ,

Nurses 59

Nurses FDA Testimonials Doctors 59

The Pharma Data

MAY 13, 2021

Testimonials are not necessarily representative of all of those who will use our products. Some of our testimonials are provided by customers who have received promotional offers in exchange for their participation. The testimonials displayed are given verbatim except for correction of grammatical or typing errors. N Engl J Med.

Disease 52

Disease Production Testimonials Science 52

The Pharma Data

MAY 14, 2021

Their waists got smaller… They also saw an improvement in fat-regulating hormones. And serves as your body’s “master regulating switch.” Do not take if you are pregnant, nursing, taking prescription or over-the-counter medication, are under the age of 18 or have, or suspect you may have a medical condition.

Packaging 52

Packaging Production Research Doctors 52

The Pharma Data

MAY 13, 2021

I could hear doctors and nurses speaking in hushed tones…. And Mary-Anne, a nurse from Arkansas, who says…. Then these hormones can’t regulate your metabolism like they should…. Along with the amount of estrogen-regulating DIM that he added as well. There were countless sensors and monitors hissing and beeping around me.

Production 52

Production Packaging Doctors Research 52

Drug & Device Law

DECEMBER 29, 2023

2023) (remote trial testimony cannot be compelled beyond Rule 45’s 100-mile limit on subpoenas) ( here ); Carson v. They excluded bogus expert testimony under Fed. Further, “adequacy” is an objective standard, that neither a plaintiff’s self-interested testimony nor equivocal health care provider testimony can touch.

Testimonials 105

Testimonials FDA Drugs Vaccine 105

Drug & Device Law

JUNE 13, 2022

The FDA’s regulations for medical device labeling generally require that such labeling include “any relevant hazards, contraindications, side effects, and precautions.” That testimony was contrary, not only to the common-law cases discussed in our prior posts , but also flatly contradicted §801.109(c). 801.109(c). Bard, Inc. ,

Testimonials 59

Testimonials Licensing Licensing FDA 59